Not found

Dan Peer, PhD

Full Affiliate Member, Research Institute
Houston Methodist


Publications

Emerging Trends in Micro- and Nanoscale Technologies in Medicine: From Basic Discoveries to Translation
Alvarez, MM, Aizenberg, J, Analoui, M, Andrews, AM, Bisker, G, Boyden, ES, Kamm, RD, Karp, JM, Mooney, DJ, Oklu, R, Peer, D, Stolzoff, M, Strano, MS, Trujillo-De Santiago, G, Webster, TJ, Weiss, PS & Khademhosseini, A 2017, ACS Nano, vol 11, no. 6, pp. 5195-5214. DOI: 10.1021/acsnano.7b01493

Advanced strategies in immune modulation of cancer using lipid-based nanoparticles
Mizrahy, S, Hazan-Halevy, I, Landesman-Milo, D, Ng, BD & Peer, D 2017, Frontiers in Immunology, vol 8, no. FEB, 69. DOI: 10.3389/fimmu.2017.00069

Orchestrating a Symphony on a Single Conjugate: Aptamer Targeting, Gene Silencing, and Immunomodulation to Enhance Antitumor Response
Ng, BD & Peer, D 2017, Molecular Therapy, vol 25, no. 1, pp. 5-7. DOI: 10.1016/j.ymthe.2016.12.003

Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes
Mizrahy, S, Hazan-Halevy, I, Dammes, N, Landesman-Milo, D & Peer, D 2017, Molecular Therapy. DOI: 10.1016/j.ymthe.2017.03.001

Harnessing nanomedicine for therapeutic intervention in glioblastoma
Gutkin, A, Cohen, ZR & Peer, D 2016, Expert Opinion on Drug Delivery, vol 13, no. 11, pp. 1573-1582. DOI: 10.1080/17425247.2016.1200557

ECM-based macroporous sponges release essential factors to support the growth of hematopoietic cells
Soffer-Tsur, N, Peer, D & Dvir, T 2016, Journal of Controlled Release. DOI: 10.1016/j.jconrel.2016.09.021

Zooming in on selectins in cancer
Kedmi, R & Peer, D 2016, Science Translational Medicine, vol 8, no. 345, 345fs11. DOI: 10.1126/scitranslmed.aag1802

Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines
Hazan-Halevy, I, Landesman-Milo, D, Rosenblum, D, Mizrahy, S, Ng, BD & Peer, D 2016, Journal of Controlled Release. DOI: 10.1016/j.jconrel.2016.07.052

RNA nanomedicines: The next generation drugs?
Singh, MS & Peer, D 2016, Current Opinion in Biotechnology, vol 39, pp. 28-34. DOI: 10.1016/j.copbio.2015.12.011

Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles
Ramishetti, S, Landesman-Milo, D & Peer, D 2016, Journal of Drug Targeting, pp. 1-7. DOI: 10.3109/1061186X.2016.1172587

Transforming Nanomedicines from Lab Scale Production to Novel Clinical Modality
Landesman-Milo, D & Peer, D 2016, Bioconjugate Chemistry, vol 27, no. 4, pp. 855-862. DOI: 10.1021/acs.bioconjchem.5b00607

Polysaccharides as nanomaterials for therapeutics
Mizrahy, S & Peer, D 2016, . in Handbook of Clinical Nanomedicine: Nanoparticles, Imaging, Therapy and Clinical Applications. vol. 1, Pan Stanford Publishing Pte. Ltd. pp. 365-407. DOI: 10.4032/9789814669214

SiRNA delivery: Current trends and future perspectives
Singh, MS & Peer, D 2016, Therapeutic Delivery, vol 7, no. 2, pp. 51-53. DOI: 10.4155/tde.15.88

Modulation of Immune Response Using Engineered Nanoparticle Surfaces
Moyano, DF, Liu, Y, Peer, D & Rotello, VM 2016, Small, vol 12, no. 1, pp. 76-82. DOI: 10.1002/smll.201502273

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
Weinstein, S, Toker, IA, Emmanuel, R, Ramishetti, S, Hazan-Halevy, I, Rosenblum, D, Goldsmith, M, Abraham, A, Benjamini, O, Bairey, O, Raanani, P, Nagler, A, Lieberman, J & Peer, D 2016, Proceedings of the National Academy of Sciences of the United States of America, vol 113, no. 1, pp. E16-E22. DOI: 10.1073/pnas.1519273113

Platelet mimicry: The emperor's new clothes?
Moghimi, SM, Hunter, AC & Peer, D 2016, Nanomedicine: Nanotechnology, Biology, and Medicine, vol 12, no. 1, pp. 245-248. DOI: 10.1016/j.nano.2015.09.005

Colitis ImmunoPET: Defining Target Cell Populations and Optimizing Pharmacokinetics
Dearling, JLJ, Daka, A, Veiga, N, Peer, D & Packard, AB 2015, Inflammatory Bowel Diseases, vol 22, no. 3, pp. 529-538. DOI: 10.1097/MIB.0000000000000677

Dielectrophoretic characterization of cells in a stationary nanoliter droplet array with generated chemical gradients
Ben-Arye, T, Park, S, Shemesh, J, Peer, D, Levenberg, S & Yossifon, G 2015, Biomedical Microdevices, vol 17, no. 5, pp. 91. DOI: 10.1007/s10544-015-9996-z

Serum chemokine network correlates with chemotherapy in non-small cell lung cancer
Yang, D, Zhou, J, Zeng, T, Yang, Z, Wang, X, Hu, J, Song, Y, Chen, L, Peer, D, Wang, X & Bai, C 2015, Cancer Letters, vol 365, no. 1, pp. 57-67. DOI: 10.1016/j.canlet.2015.05.001

Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes
Hazan-Halevy, I, Rosenblum, D, Weinstein, S, Bairey, O, Raanani, P & Peer, D 2015, Cancer Letters, vol 364, no. 1, pp. 59-69. DOI: 10.1016/j.canlet.2015.04.026